Skip to content
Register Sign in Wishlist

Networks of Innovation
Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995

$37.00 USD

Award Winner
Louis Galambos, Jane Eliot Sewell
View all contributors
  • Date Published: February 2011
  • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • format: Adobe eBook Reader
  • isbn: 9780511891144

$ 37.00 USD
Adobe eBook Reader

You will be taken to ebooks.com for this purchase
Buy eBook Add to wishlist

Other available formats:
Paperback


Looking for an inspection copy?

This title is not currently available on inspection

Description
Product filter button
Description
Contents
Resources
Courses
About the Authors
  • Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.

    Awards

    • Winner of the Thomas Newcomen Award for the best book in business history, 1995–1997

    Reviews & endorsements

    'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity

    ×

    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?

    ×

    Product details

    • Date Published: February 2011
    • format: Adobe eBook Reader
    • isbn: 9780511891144
    • contains: 4 colour illus.
    • availability: This ISBN is for an eBook version which is distributed on our behalf by a third party.
  • Table of Contents

    Preface
    1. 1894: 'The foremost medical question of the day'
    2. The Mulford story
    3. A Sharp & Dohme interlude
    4. The virology network and a new programme at Merck, Sharp & Dohme
    5. Hilleman's innovations: first phase, measles-mumps-rubella
    6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama
    7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae
    8. New networks, new leadership: the Hepatitis B vaccines
    9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations
    A word about sources.

  • Author

    Louis Galambos, The Johns Hopkins University

    With

    Jane Eliot Sewell

    Contributors

    Louis Galambos, Jane Eliot Sewell

    Awards

    • Winner of the Thomas Newcomen Award for the best book in business history, 1995–1997

Sign In

Please sign in to access your account

Cancel

Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email lecturers@cambridge.org

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.

Cancel

Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

×
Please fill in the required fields in your feedback submission.
×